This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 102/5/597    most recent CIRCRESAHA.107.165464v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonzalez, A. Articles by Leri, A. Search for Related Content PubMed PubMed Citation Articles by Gonzalez, A. Articles by Leri, A. Related Collections Congestive Cell biology/structural biology Gene expression Growth factors/cytokines Myogenesis

(Circulation Research. 2008;102:597.)
© 2008 American Heart Association, Inc.

Integrative Physiology

Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan

Arantxa Gonzalez^*, Marcello Rota^*, Daria Nurzynska^*, Yu Misao, Jochen Tillmanns, Caroline Ojaimi, M. Elena Padin-Iruegas, Patrick Müller, Grazia Esposito, Claudia Bearzi, Serena Vitale, Buddhadeb Dawn, Santosh K. Sanganalmath, Mathue Baker, Thomas H. Hintze, Roberto Bolli, Konrad Urbanek, Toru Hosoda, Piero Anversa, Jan Kajstura, Annarosa Leri

From the Departments of Anesthesia and Medicine and Division of Cardiology (A.G., M.R., D.N., Y.M., J.T., M.E.P.-I., P.M., G.E., C.B., S.V., M.B., K.U., T.H., P.A., J.K., A.L.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; Department of Physiology (C.O., T.H.H.), New York Medical College, Valhalla, New York 10595; and Institute of Molecular Cardiology (B.D., S.K.S., R.B.), University of Louisville, Ky.

Correspondence to Annarosa Leri, MD, Departments of Anesthesia and Medicine and Division of Cardiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. E-mail aleri{at}zeus.bwh.harvard.edu

Heart failure is the leading cause of death in the elderly, but whether this is the result of a primary aging myopathy dictated by depletion of the cardiac progenitor cell (CPC) pool is unknown. Similarly, whether current lifespan reflects the ineluctable genetic clock or heart failure interferes with the genetically determined fate of the organ and organism is an important question. We have identified that chronological age leads to telomeric shortening in CPCs, which by necessity generate a differentiated progeny that rapidly acquires the senescent phenotype conditioning organ aging. CPC aging is mediated by attenuation of the insulin-like growth factor-1/insulin-like growth factor-1 receptor and hepatocyte growth factor/c-Met systems, which do not counteract any longer the CPC renin–angiotensin system, resulting in cellular senescence, growth arrest, and apoptosis. However, pulse-chase 5-bromodeoxyuridine–labeling assay revealed that the senescent heart contains functionally competent CPCs that have the properties of stem cells. This subset of telomerase-competent CPCs have long telomeres and, following activation, migrate to the regions of damage, where they generate a population of young cardiomyocytes, reversing partly the aging myopathy. The senescent heart phenotype and heart failure are corrected to some extent, leading to prolongation of maximum lifespan.

Key Words: aging cardiomyopathy • cardiac stem cells • telomere–telomerase system

This article has been cited by other articles:

				P. Spallarossa, P. Altieri, C. Aloi, S. Garibaldi, C. Barisione, G. Ghigliotti, G. Fugazza, A. Barsotti, and C. Brunelli Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2169 - H2181. [Abstract] [Full Text] [PDF]

				K. M. Fischer, C. T. Cottage, W. Wu, S. Din, N. A. Gude, D. Avitabile, P. Quijada, B. L. Collins, J. Fransioli, and M. A. Sussman Enhancement of Myocardial Regeneration Through Genetic Engineering of Cardiac Progenitor Cells Expressing Pim-1 Kinase Circulation, November 24, 2009; 120(21): 2077 - 2087. [Abstract] [Full Text] [PDF]

				J. Ferreira-Martins, C. Rondon-Clavo, D. Tugal, J. A. Korn, R. Rizzi, M. E. Padin-Iruegas, S. Ottolenghi, A. De Angelis, K. Urbanek, N. Ide-Iwata, et al. Spontaneous Calcium Oscillations Regulate Human Cardiac Progenitor Cell Growth Circ. Res., October 9, 2009; 105(8): 764 - 774. [Abstract] [Full Text] [PDF]

				T. Hosoda, D. D'Amario, M. C. Cabral-Da-Silva, H. Zheng, M. E. Padin-Iruegas, B. Ogorek, J. Ferreira-Martins, S. Yasuzawa-Amano, K. Amano, N. Ide-Iwata, et al. Clonality of mouse and human cardiomyogenesis in vivo PNAS, October 6, 2009; 106(40): 17169 - 17174. [Abstract] [Full Text] [PDF]

				M. E. Padin-Iruegas, Y. Misao, M. E. Davis, V. F.M. Segers, G. Esposito, T. Tokunou, K. Urbanek, T. Hosoda, M. Rota, P. Anversa, et al. Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction Circulation, September 8, 2009; 120(10): 876 - 887. [Abstract] [Full Text] [PDF]

				C. Stamm, Y.-H. Choi, B. Nasseri, and R. Hetzer A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 215 - 229. [Abstract] [PDF]

				Z. Li, A. Lee, M. Huang, H. Chun, J. Chung, P. Chu, G. Hoyt, P. Yang, J. Rosenberg, R. C. Robbins, et al. Imaging survival and function of transplanted cardiac resident stem cells. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1229 - 1240. [Abstract] [Full Text] [PDF]

				L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing Cardiovasc Res, February 1, 2009; 81(2): 244 - 252. [Abstract] [Full Text] [PDF]

				M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G. P. Meyer, A. Ganser, H. Drexler, and K. C. Wollert Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction Eur. Heart J., December 1, 2008; 29(23): 2851 - 2858. [Abstract] [Full Text] [PDF]

				L. S.M. Wong, R. A. de Boer, N. J. Samani, D. J. van Veldhuisen, and P. van der Harst Telomere biology in heart failure Eur J Heart Fail, November 1, 2008; 10(11): 1049 - 1056. [Abstract] [Full Text] [PDF]

				G. Amir, X. Ma, V. M. Reddy, F. L. Hanley, O. Reinhartz, C. Ramamoorthy, and R. K. Riemer Dynamics of Human Myocardial Progenitor Cell Populations in the Neonatal Period Ann. Thorac. Surg., October 1, 2008; 86(4): 1311 - 1319. [Abstract] [Full Text] [PDF]

				M. Carlsson, N. F. Osman, P. C. Ursell, A. J. Martin, and M. Saeed Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H522 - H532. [Abstract] [Full Text] [PDF]

				M. Tjwa and S. Dimmeler A Nucleolar Weapon in Our Fight for Regenerating Adult Hearts: Nucleostemin and Cardiac Stem Cells Circ. Res., July 3, 2008; 103(1): 4 - 6. [Full Text] [PDF]

				M. Rota, M. E. Padin-Iruegas, Y. Misao, A. De Angelis, S. Maestroni, J. Ferreira-Martins, E. Fiumana, R. Rastaldo, M. L. Arcarese, T. S. Mitchell, et al. Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function Circ. Res., July 3, 2008; 103(1): 107 - 116. [Abstract] [Full Text] [PDF]

				S. Dimmeler and A. Leri Aging and Disease as Modifiers of Efficacy of Cell Therapy Circ. Res., June 6, 2008; 102(11): 1319 - 1330. [Abstract] [Full Text] [PDF]

				Highlights From The Literature Physiology, June 1, 2008; 23(3): 128 - 130. [Full Text] [PDF]